Anson Funds Management’s Zimmer Biomet ZBH Stock Holding History

Anson Funds Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,502	Closed	-$509K	–	109
2019 Q4	$509K	Buy	+3,502	New	+$483K	0.59%	52

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Anson Funds Management's ZBH Position: Q1 2020 in Review

Anson Funds Management sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 3,502 shares — an estimated $509K sold.

Anson Funds Management first reported a position in ZBH in Q4 2019 and held it in 1 quarter. The position peaked at $509K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Anson Funds Management reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Anson Funds Management sold 3,502 Zimmer Biomet shares in Q1 2020, an estimated $509K.
Anson Funds Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 1 quarter.
Anson Funds Management's Zimmer Biomet position peaked at $509K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Anson Funds Management's 13F filing for Q1 2020, filed 15 May 2020.